Sangamo Therapeutics SGMO Sparks Speculation of a Turnaround as Investor Sentiment Shifts Cytosorbents CTSO Q1 2026 Disappoints EPS 008 Below 006 Views CleanCore Solutions ZONE Stalls at 059 Breakout or Breakdown 20260515